Tag Archives: Kayte Spector-Bagdady

How do we explain to patients what genetic test results might mean for their baby when they have only been validated in other populations?

Posted on August 21, 2017 by

Expanded Carrier Screening for an Increasingly Diverse Population: Embracing the Promise of the Future or Ignoring the Sins of the Past? Event Flyer Race and ethnic groups have been tracking heritable conditions endemic within their communities for decades, but past … Continue reading →

Posted in Bioethics Events, Brownbag & Webinar Series, Outreach, Public Seminar Series | Tagged , , , , , , ,

What can we learn from historical violations of research ethics?

Posted on October 29, 2015 by

Current public health policies are inherently influenced by a case-based infrastructure. But what is lost and what is gained by bioethical policies that are generally reactionary? What can we learn from worst-case historical scenarios that seem inconceivable in our current human subjects research environment? Continue reading →

Posted in Bioethics Events, Brownbag & Webinar Series, Public Seminar Series | Tagged , , , , ,

Welcome to FDA Enforcement

Posted on January 2, 2014 by

This post is a part of our Bioethics in the News series. For more information, click here. By Kayte Spector-Bagdady, J.D., M.Bioethics  “This is me, my DNA. It helps make me who I am…I might have an increased risk of heart … Continue reading →

Posted in Bioethics in the News | Tagged , , , , , , , , | 1 Comment